
Profitability, historical returns, and peer comparisons.
According to Lunai Bioworks Inc.’s latest financial reports and current stock price. The company's current ROE is 31.55%. This represents a change of 208.85% compared to the average of 10.21% of the last 4 quarters.
The mean historical ROE of Lunai Bioworks Inc. over the last ten years is 91.57%. The current 31.55% ROE has changed -65.55% with respect to the historical average. Over the past ten years (40 quarters), RENB's ROE was at its highest in in the June 2025 quarter at 593.60%. The ROE was at its lowest in in the September 2024 quarter at -45.07%.
Average
91.57%
Median
-41.15%
Minimum
-156.20%
Maximum
833.76%
Discovering the peaks and valleys of Lunai Bioworks Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 920.93%
Maximum Annual ROE = 833.76%
Minimum Annual Increase = -1344.41%
Minimum Annual ROE = -156.20%
| Year | ROE | Change |
|---|---|---|
| 2026 | 39.47% | -95.27% |
| 2025 | 833.76% | -1344.41% |
| 2024 | -67.00% | -21.49% |
| 2023 | -85.34% | -45.37% |
| 2022 | -156.20% | 920.93% |
The current ROE of Lunai Bioworks Inc. (RENB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
268.75%
5-year avg
112.94%
10-year avg
91.57%
Lunai Bioworks Inc.’s ROE is greater than Angion Biomedica Corp. (-1266.43%), greater than Marinus Pharmaceuticals, Inc. (-213.02%), less than LianMedical (11.78%), less than Opus Genetics, Inc. (1.15%), greater than Grace Therapeutics, Inc. (-35.78%), greater than Allakos Inc. (-93.54%), greater than Serina Therapeutics, Inc. (-222.42%), greater than Oruka Therapeutics, Inc. (-20.76%), less than Satsuma Pharmaceuticals, Inc. (125.24%), greater than Freeline Therapeutics Holdings plc (-102.94%),
| Company | ROE | Market cap |
|---|---|---|
| -1266.43% | $30.11M | |
| -213.02% | $30.37M | |
| 11.78% | $4.26M | |
| 1.15% | $355.25M | |
| -35.78% | $29.46M | |
| -93.54% | $29.74M | |
| -222.42% | $25.35M | |
| -20.76% | $6.71B | |
| 125.24% | $36.47M | |
| -102.94% | $28.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lunai Bioworks Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lunai Bioworks Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Lunai Bioworks Inc.'s ROE?
How is the ROE calculated for Lunai Bioworks Inc. (RENB)?
What is the highest ROE for Lunai Bioworks Inc. (RENB)?
What is the 3-year average ROE for Lunai Bioworks Inc. (RENB)?
What is the 5-year average ROE for Lunai Bioworks Inc. (RENB)?
How does the current ROE for Lunai Bioworks Inc. (RENB) compare to its historical average?